Innospec Inc. IOSP
98.72
1.85
1.91%
as of 25 Sep
- Market cap
- $2.4B
- P/E
- 20.1×
Follow IOSP
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 16.35 | 15.87 | 16.58 |
P/S ratio |
1.07 | 1.07 | 1.01 | 1.09 | |
P/FCF ratio |
68.19 | 29.80 | 32.89 | 39.02 | |
P/Operating CF |
50.29 | 31.01 | 102.79 | 278.58 | |
P/B ratio |
1.47 | 1.43 | 1.34 | 1.48 | |
Price to Tangible BV |
2.28 | 2.20 | 2.05 | 2.26 | |
EV/Sales |
0.94 | 0.93 | 0.87 | 0.98 | |
EV/EBITDA |
8.98 | 9.55 | 9.40 | 10.55 | |
EV/Operating CF |
16.45 | 11.96 | 12.24 | 14.46 | |
EV/FCF |
60.05 | 25.88 | 28.40 | 34.97 | |
Quick Ratio |
1.74 | 1.76 | 1.92 | 1.79 | |
Current Ratio |
2.78 | 2.79 | 2.98 | 2.78 | |
Net Debt/EBITDA |
(7.28) | (7.88) | (6.23) | (5.03) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.99 | 1.00 | 1.00 | 1.01 | |
Operating CF/Net income |
2.95 | 1.30 | 0.58 | 0.23 | |
Capex/Depreciation |
(0.71) | 2.11 | (1.38) | (1.65) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
3.10% | 2.41% | 2.91% | 2.89% | |
Selling, General and Administrative Expense of Revenue |
16.27% | 15.21% | 17.32% | 17.16% | |
Intangible Assets out of Total Assets |
0.26 | 0.25 | 0.26 | 0.25 | |
Share Based Compensation of Revenue |
0.20% | 0.68% | 0.35% | 0.45% | |
Graham Net Nets |
0.26 | 0.27 | 0.29 | 0.26 | |
Graham Number |
0.00 | 75.11 | 75.16 | 77.82 | |
Earnings Yield |
(0.06%) | 6.11% | 6.30% | 6.03% | |
Free Cash Flow Yield |
1.47% | 3.36% | 3.04% | 2.56% | |
Revenue per Share |
17.79 | 18.31 | 18.29 | 19.94 | |
Operating CF per Share |
1.53 | 2.47 | 0.71 | 0.29 | |
Capex per Share |
(0.89) | (0.82) | (0.55) | (0.67) | |
Free Cash Flow per Share |
0.64 | 1.64 | 0.16 | (0.38) | |
Cash per Share |
10.90 | 11.76 | 11.67 | 10.15 | |
Shareholders Equity per Share |
52.46 | 53.57 | 54.58 | 54.82 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
52.46 | 53.57 | 54.58 | 54.82 | |
Free Cash Flow |
15.90 | 40.90 | 3.90 | (9.30) | |
Working Capital |
632.70 | 644.50 | 664.30 | 656.60 | |
Capital Expenditures |
(22.20) | (20.50) | (13.70) | (16.50) | |
Net Current Asset Value |
492.30 | 505.10 | 531.50 | 529.50 | |
EV/EBIT |
13.63 | 12.77 | 12.65 | 13.95 | |
Capex to Sales |
0.05 | 0.05 | 0.03 | 0.03 | |
Net Profit Margin |
2.92% | 10.40% | 6.71% | 6.27% | |
Price to Operating Income |
15.48 | 14.71 | 14.65 | 15.56 | |
| Other line items | |||||
Average Receivables |
338.55 | 342.00 | 348.85 | 372.35 | |
Average Payables |
165.60 | 169.25 | 154.00 | 159.40 | |
Average Inventory |
332.25 | 315.15 | 318.45 | 337.05 | |
Average Assets |
1,798.55 | 1,783.55 | 1,797.20 | 1,826.15 | |
Average Common Equity |
1,275.25 | 1,274.50 | 1,308.95 | 1,326.25 |
Columns are period end dates